Skip to main content

Table 2 Comparison of primary outcome measures in two groups of patients treated with IVIG and standard treatment group

From: The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients’: a retrospective, multi-centric cohort study

Feature

Standard group

IVIG group

Statistics

p value

No. of patients (%)

109 (59.6)

74 (40.4)

ICU length of stay (days)

7.33

9.46

1.848

0.066

Duration of hospitalization (days)

11.10

13.74

2.060

0.041

Duration of mechanical ventilation (days)

4.14

4.23

0.119

0.905

Mortality (%)

48 (44.03)

42 (56.75)

2.367

0.124

  1. No: number(s); ICU: intensive care unit; IVIG: intravenous immunoglobulin